- Citation name: Khademhosseini, A.
- Affiliation: University of California-Los Angeles (UCLA)
- State: CA
- Country: USA
Ali Khademhosseini is the Levi Knight Professor of Bioengineering, Chemical Engineering and Radiology and the Founding Director of the Center for Minimally Invasive Therapeutics at University of California-Los Angeles (UCLA). He joined UCLA in Nov. 2017 from Harvard University where he was Professor of Medicine at Harvard Medical School (HMS), and faculty at Harvard-MIT Health Sciences and Technology and the Wyss Institute. At Harvard, he directed the Biomaterials Innovation Research Center (BIRC) a world renown bioengineering initiative comprised of over 100 researchers. He is a leader in applying bioengineering solutions to precision medicine. His large and interdisciplinary group is interested in developing ‘personalized’ solutions that utilize micro- and nanoscale technologies to enable a range of therapies for organ failure, cardiovascular disease and cancer. He has authored >550 journal papers and 60 books/chapters. He is one of the most cited young faculty in the world with >40,000 citations and H-index >100.